Methodological quality of the review: High confidence
Author: Akbari M, Akbari S, Pasquale LR
Geographical coverage: Not reported
Sector: Glaucoma
Sub-sector: Mortality
Equity focus: None specified
Review type: Other review
Quantitative synthesis method: Meta-analysis
Qualitative synthesis method: Not applicable
Background: Primary open angle glaucoma (POAG) is a multifactorial, chronic, progressive disease that results in damaged structural integrity of the optic nerve and diminished visual function. Understanding the relationship between POAG and mortality is critical, with an estimated 44.7 million people affected worldwide by the year 2010. If true mortality rates in patients with POAG differ from those of the general population, this information may provide insight into the underlying disease etiology.
Objectives: To conduct a meta-analysis to estimate the relationship between primary open angle glaucoma (POAG) and mortality.
Main findings: A total of nine studies were included in the review. One study was a population-based, annual, cross-sectional study, while the others were prospective cohorts. The mean time follow-up ranged from 4.5 to 16 years. Collectively, the sample size was 146,848, with 2811 classified as having POAG. Criteria used for POAG and mortality assessment varied between studies.
A significant risk was not detected in the final pooled analysis (RR, 1.13; 95% confidence interval [CI], 0.97-1.31) for all-cause mortality. A meta-regression across mean follow-up time, age, and sex was not significant. A meta-regression across diabetes status in three of the nine studies did not demonstrate significant results (P=.94). Sub-group analysis on cardiovascular mortality from four of the nine studies was marginally significant (RR, 1.20; 95% CI, 1.00-1.43; P=.05), but insignificant after removal of a study in which POAG was ascertained by self and proxy report (RR, 1.12; 95% CI, 0.87-1.46).
Authors note that this meta-analysis does not demonstrate an association between POAG and all-cause or cardiovascular mortality. A Q test for heterogeneity was significant in the primary analysis (P= .04), but insignificant for the secondary analysis (P= .41). The I2 statistic failed to show significant heterogeneity in both primary and secondary analyses.
Methodology: Studies were included if they:
(a) Reported POAG or IOP status
(b) Excluded secondary glaucoma
(c) Reported all-cause mortality relative risks (RR) with 95% confidence intervals (CI)
(d) Included a control group
(e) Were written in English
Two authors independently conducted searches on the PUBMED, EMBASE and Web of Science databases without date restrictions. A combination of text words and Medical Subject Headings of the National Library of Medicine or subject headings was used in the database search. The titles of all articles were read and the relevant abstracts evaluated. The bibliographies were reviewed, manual searches were conducted and authors were contacted for further potentially relevant studies.
Study quality was assessed using the suggested framework from another publication. Variables examined included adequate explanation of study sampling and diagnostic criteria for POAG, outcome results for high proportion of the population, and appropriate statistical adjustment of the outcome. Two reviewers independently extracted data on included studies including: study reference details, methods and patient characteristics.
Authors used the Q test to evaluate study heterogeneity and the I2 statistic to estimate the proportion of total variability of the pooled estimate due to between-study variation. Pooled estimates used a random-effects model. Additionally, authors performed a meta-regression to assess heterogeneity in the length of follow-up age, sex, age and diabetes status across studies. In a sub-group analysis, authors assessed the relationship between POAG and cardiovascular mortality using four studies in which data were available. A sensitivity analysis was performed to assess the robustness of the pooled estimates of all-cause and cardiovascular mortality.
Applicability/external validity: Authors note excluding studies limited to non-generalizable patients and including studies reporting an adequate explanation of study sampling. Studies included in the meta-analysis were conducted in a population of African descendent, Asians and European descendants.
Geographic focus: Authors did not report the geographical location of studies included in the review.
Summary of quality assessment: Overall, there is high confidence in the conclusions about the effects of this review. Authors used appropriate methods to pool data for analyses and appropriately discussed and acknowledged heterogeneity across included studies. However, minor limitations were identified. Authors excluded studies written in languages other than English, however it was noted that abstracts were not available to determine its eligibility for inclusion. Authors appropriately discussed limitations of the review and did not draw strong policy conclusions.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.